Medical Devices
Voyageur Pharmaceuticals Submits Permit Application for Barite Project, Aiming to Become North American Supplier of Pharmaceutical Barium Contrast Agents
Voyageur Pharmaceuticals has submitted a multi-year exploration permit application for its Frances Creek barite project in British Columbia, which could position the company as a secure North American source of pharmaceutical-grade barium contrast products.
Radioactive Collagen Tiles Reduce Brain Cancer Recurrence in Clinical Trial
A clinical trial found that placing radioactive collagen tiles into the brain cavity during tumor removal dramatically cuts recurrence and extends survival, offering new hope for brain cancer treatment.
Regentis Biomaterials Set to Begin European Surgeon Training for GelrinC Cartilage Implant
Regentis Biomaterials plans to commence surgeon training activities in Q3 2026 to support the commercial rollout of its CE Mark-approved GelrinC treatment for knee cartilage lesions, addressing a significant unmet need in Europe.
Regentis Biomaterials Advances European Commercial Launch for GelrinC with Surgeon Training Program
Regentis Biomaterials plans to start European surgeon training for its CE Mark-approved knee cartilage treatment GelrinC in Q3 2026, marking a key step toward commercialization.
NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference, Highlighting OneRF Platform Progress
NeuroOne Medical Technologies will present at the Planet MicroCap Las Vegas 2026 Conference, providing updates on its OneRF platform for brain treatment, pain, and drug delivery, signaling continued momentum in neurological device commercialization.
Regentis Biomaterials' GelrinC Targets Large Untapped Market for Off-the-Shelf Cartilage Repair
Regentis Biomaterials is advancing its GelrinC platform toward commercialization, aiming to fill the gap in FDA-approved off-the-shelf regenerative cartilage repair for the 470,000 annual U.S. knee cartilage damage cases.
HeartBeam Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in patients with chest pain, potentially enabling earlier detection and treatment.
Viromed Medical AG Completes Study on Cold Plasma Application in the Lung, Shows Promise for Treating Ventilator-Associated Pneumonia
Viromed Medical AG announces successful completion of a multi-year study on cold atmospheric plasma in the lung, demonstrating potential as a non-pharmacological treatment for severe infectious lung diseases, with first successful patient applications already achieved.
Regentis Biomaterials Advances Simplified Cartilage Repair Platform Toward Key Milestones
Regentis Biomaterials is moving its cell-free hydrogel implant GelrinC toward U.S. market entry, targeting a $3 billion knee cartilage repair market with a simplified procedure that could replace traditional microfracture and cell-based therapies.
Regentis Biomaterials Targets $3 Billion U.S. Knee Cartilage Repair Market with Novel Off-the-Shelf Solution
Regentis Biomaterials' GelrinC platform offers a potential first-in-class, ready-to-use knee cartilage repair treatment with superior pain relief and faster recovery, advancing through U.S. Phase III trials.
HeartBeam's Portable ECG Device Shows Promise in Identifying Heart Attack Risk, Study Finds
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in chest pain patients, with accuracy rising to 92.9% when a baseline ECG is available.
Ocumetics Strengthens Balance Sheet with $1.4 Million Debt Conversion Ahead of Key Clinical Milestones
Ocumetics Technology Corp. converts $1.4 million of debenture principal into equity, reducing debt by 35% and improving financial flexibility as it prepares for FDA submission.
Regentis Biomaterials Nears Key Milestones for Simplified Cartilage Repair Implant
Regentis Biomaterials advances GelrinC, a single-step hydrogel implant for knee cartilage repair, targeting a $3 billion U.S. market with CE Mark approval and a Phase III trial over 50% enrolled.
Regentis Biomaterials Advances Cell-Free Knee Cartilage Implant, Targeting Major Market Gap
Regentis Biomaterials is advancing GelrinC, a ready-to-use hydrogel implant for knee cartilage repair, addressing a U.S. market of approximately 470,000 annual cases lacking an approved off-the-shelf regenerative solution.
Regentis Biomaterials Advances Toward Key Milestones for Simplified Cartilage Repair Platform
Regentis Biomaterials Ltd. is progressing its GelrinC hydrogel implant toward European commercialization and U.S. FDA submission, targeting a $3 billion market for knee cartilage repair with a cell-free, single-step procedure.
Regentis Biomaterials Targets $3 Billion Knee Cartilage Repair Market with Off-the-Shelf GelrinC Platform
Regentis Biomaterials’ GelrinC platform shows promise as a first-in-class, off-the-shelf solution for knee cartilage repair, with clinical data indicating approximately 100% greater pain improvement versus microfracture and a clear path to U.S. market entry.
Regentis Biomaterials Targets Major Gap in Knee Cartilage Repair with Off-the-Shelf Implant
Regentis Biomaterials Ltd. is advancing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could address a significant unmet need in the U.S. market where no off-the-shelf regenerative solution currently exists.
NeuroOne to Present New Trigeminal Nerve Ablation System and Drug Delivery Platform at ASSFN Meeting
NeuroOne Medical Technologies will showcase its recently FDA-cleared OneRF® Trigeminal Nerve Ablation System and provide updates on its investigational SEEG-Drug Delivery System at the 2026 ASSFN Biennial Meeting, highlighting advancements in neurological surgery.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG System
HeartBeam is developing a cable-free, portable ECG system to address pre-hospital delays in cardiac care by enabling clinical-grade data collection outside clinical settings.
Regentis Biomaterials Targets Knee Cartilage Repair Market with Off-the-Shelf Hydrogel Implant
Regentis Biomaterials advances GelrinC, a cell-free hydrogel implant for knee cartilage repair, as clinical trials progress and a new manufacturing process scales production.
Oncotelic Therapeutics Advances CNS Drug Delivery Strategy Amid BBB Breakthroughs
Oncotelic Therapeutics' $12.5M monetization of its CNS delivery system highlights growing industry focus on blood-brain barrier bypass technologies, unlocking new biotech market opportunities.
New Whitening Product Aims to Address Tooth Sensitivity and Gum Irritation from Peroxide-Based Systems
A new whitening system from ioTech International promises professional-strength results without the sensitivity and irritation commonly caused by peroxide-based products.
Regentis Biomaterials Targets $3 Billion U.S. Knee Cartilage Repair Market with GelrinC
Regentis Biomaterials’ GelrinC offers a potential first-in-class, off-the-shelf solution for knee cartilage repair, with Phase III trial underway and CE Mark approval in Europe.
NeuroOne Medical Technologies Restates Q2 Results Due to Revenue Recognition Error, Reaffirms FY2026 Guidance
NeuroOne Medical Technologies will restate its fiscal second-quarter financials after an error overstated revenue by $0.5 million, but the company reaffirms its full-year product revenue guidance of at least $10.5 million.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG Platform
HeartBeam Inc. is developing a cable-free, high-fidelity ECG platform to address pre-hospital delays in cardiac care, with potential for future heart attack detection.
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Solution for Knee Cartilage Repair, Targeting a 472,500-Procedure Gap
Regentis Biomaterials is developing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could fill a market gap as no approved off-the-shelf regenerative solution exists in the U.S., with a pivotal FDA trial now over 50% enrolled and a new manufacturing process boosting yield by 400%.
Invisalign Gains Ground as Nashville Families Seek Discreet Orthodontic Options
Lucas Orthodontic Group expands Invisalign offerings for Nashville families, responding to growing patient demand for clear aligners as a discreet alternative to traditional braces.
Caggiano Orthodontics Expands vPro Accelerated Invisalign in Parsippany, NJ
Caggiano Orthodontics retains Diamond-tier Invisalign status and expands vPro accelerated treatment, offering up to 50% shorter treatment timelines for qualifying patients in Morris County.
Wearable Wristband Shows Promise in Detecting Cardiac Arrest, Study Finds
New research published in Circulation: Arrhythmia and Electrophysiology demonstrates that a smart wristband using photoplethysmography can detect cardiac arrest with 92% accuracy in a clinical setting, potentially enabling faster emergency response and improved survival for out-of-hospital cardiac arrest.
Oragenics Advances Phase IIa Concussion Trial, Eyes CNS Device Licensing
Oragenics provided a shareholder update on its Phase IIa trial of ONP-002 for concussion in Australia, plans for U.S. regulatory meetings, and a letter of intent to license a complementary CNS medical device.